The tumultuous journey of nesiritide: past, present, and future
- PMID: 19808264
- PMCID: PMC4684180
- DOI: 10.1161/CIRCHEARTFAILURE.108.776294
The tumultuous journey of nesiritide: past, present, and future
Comment on
-
Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial.Circ Heart Fail. 2008 May;1(1):9-16. doi: 10.1161/CIRCHEARTFAILURE.108.767483. Circ Heart Fail. 2008. PMID: 19808265 Clinical Trial.
References
-
- Cataliotti A, Burnett JC., Jr Natriuretic peptides: novel therapeutic targets in heart failure. J Investig Med. 2005;53:378–384. - PubMed
-
- Heublein DM, Huntley BK, Boerrigter G, Cataliotti A, Sandberg SM, Redfield MM, Burnett JC., Jr Immunoreactivity and guanosine 3′,5′-cyclic monophosphate activating actions of various molecular forms of human B-type natriuretic peptide. Hypertension. 2007;49:1114–1119. - PubMed
-
- Liang F, O’Rear J, Schellenberger U, Tai L, Lasecki M, Schreiner GF, Apple FS, Maisel AS, Pollitt NS, Protter AA. Evidence for functional heterogeneity of circulating B-type natriuretic peptide. J Am Coll Cardiol. 2007;49:1071–1078. - PubMed
-
- Charloux A, Piquard F, Doutreleau S, Brandenberger G, Geny B. Mechanisms of renal hyporesponsiveness to ANP in heart failure. Eur J Clin Invest. 2003;33:769–778. - PubMed
-
- Bryan PM, Xu X, Dickey DM, Chen Y, Potter LR. Renal hyporesponsiveness to atrial natriuretic peptide in congestive heart failure results from reduced atrial natriuretic peptide receptor concentrations. Am J Physiol Renal Physiol. 2007;292:F1636–F1644. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
